文献速递心外重症与机械循环支持

左心室辅助装置患者接受减重手术的结局

Outcomes of bariatric surgery in patients with left ventricular assist device.
PubMed 文献 · J Heart Lung Transplant · 2022-04-10

该研究基于2012至2019年植入左心室辅助装置(LVAD)且至少为II度肥胖的Medicare受益人,识别其中接受减重手术的患者。减重术后30天主要不良心血管事件(MACE)为6.1%,30天死亡率<5.5%,1年死亡率为12.6%;减重术后心力衰竭再入院负担下降(发生率比0.20,95%CI 0.11-0.38,p<0.001),且与随访期间心脏移植概率升高相关(亚分布HR 2.95,95%CI 2.09-4.17,p<0.001)。

要点

  • LVAD患者中至少II度肥胖者占19.4%(2798例),其中7.1%(198例)接受了减重手术。
  • 减重术后30天MACE为6.1%,30天死亡率<5.5%,1年死亡率为12.6%。
  • 减重手术与心力衰竭再入院负担下降及心脏移植概率升高相关(亚分布HR 2.95)。

核心结论

  • 在LVAD支持的患者中,减重手术与心力衰竭事件减少及心脏移植机会升高相关。

研究设计与样本

  • 基于2012至2019年植入LVAD且至少为II度肥胖的Medicare受益人,识别在LVAD植入住院期间或之后接受减重手术的患者。

主要发现

  • 2012至2019年植入LVAD的患者中,2798例(19.4%)至少为II度肥胖,198例(7.1%)接受了减重手术(24例在同一次住院期间,174例在中位702天后)。
  • 减重术后30天MACE为6.1%,30天死亡率<5.5%,1年死亡率为12.6%。
  • 减重术后心力衰竭再入院负担下降(发生率比0.20,95%CI 0.11-0.38,p<0.001)。
  • 37例在中位371天(IQR 246-575天)后接受心脏移植,13例因恢复而移除LVAD。
  • 在时间依赖、竞争风险Cox回归中,减重手术与随访期间心脏移植概率升高3倍相关(亚分布HR 2.95,95%CI 2.09-4.17,p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Class II obesity affects 1 in 5 patients with left ventricular assist device (LVAD) and is considered a potential barrier to heart transplantation (HT). Studies about the outcomes of bariatric surgery in this population are scarce. METHODS: We identified Medicare beneficiaries who had an LVAD placed from 2012 to 2019 and had at least class II obesity at the time of LVAD placement and identified patients who underwent bariatric surgery during or after the LVAD implantation admission. The primary outcome was major adverse cardiovascular events (MACE) at 30 days (mortality, cerebral hemorrhage, or ischemic stroke) after bariatric surgery. RESULTS: Among patients who underwent LVAD implantation from 2012 to 2019, 2798 (19.4%) had at least class II obesity, and 198 (7.1%) patients had bariatric surgery (24 on same admission and 174 after a median of 702 days). After bariatric surgery in LVAD patients, 30-day MACE was 6.1%, 30-day mortality was <5.5%, and 1-year mortality was 12.6%. Heart failure readmission burden declined after bariatric surgery (incidence rate ratio 0.20 (95% CI 0.11-0.38), p < 0.001). Thirty-seven patients underwent HT after a median of 371 days (IQR 246-575 days), and 13 patients underwent LVAD explant due to recovery. On time-dependent, competing risk, Cox regression, bariatric surgery was associated with a 3-fold higher probability of HT in follow-up compared to patients who did not get bariatric surgery (sub-distribution HR 2.95, 95% CI 2.09-4.17, p < 0.001). CONCLUSIONS: Bariatric surgery in patients with LVAD support is associated with decreased heart failure events and higher chances of heart transplantation.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. McElderry B, Alvarez P, Hanna M, et al. Outcomes of bariatric surgery in patients with left ventricular assist device. J Heart Lung Transplant. 2022. PMID: 35537903. doi:10.1016/j.healun.2022.04.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。